Dual GIP and GLP-1 receptor agonist tirzepatide alleviates hepatic steatosis and modulates gut microbiota and bile acid metabolism in diabetic mice
2025 · International Immunopharmacology · 24 citations
https://doi.org/10.1016/j.intimp.2024.113937
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
6
Papers
149
Citations
4
h-index
3
i10-index
Weiting Hu is an academic researcher from Shanxi Medical University. The author has contributed to research in topics: Diabetes Treatment and Management & Adipokines, Inflammation, and Metabolic Diseases & Diabetes Management and Research. The author has an h-index of 4, co-authored 6 publications.
https://doi.org/10.1016/j.intimp.2024.113937
https://doi.org/10.1186/s12951-025-03427-6
https://doi.org/10.1186/s40001-025-03188-w
Click to start Chat